Literature DB >> 25198218

Pathophysiology, epidemiology, and assessment of obesity in adults.

Neil S Skolnik1, Donna H Ryan.   

Abstract

Obesity is a multifactorial disease that results from a combination of both physiological, genetic, and environmental inputs. Obesity is associated with adverse health consequences, including T2DM, cardiovascular disease, musculoskeletal disorders, obstructive sleep apnea, and many types of cancer. The probability of developing adverse health outcomes can be decreased with maintained weight loss of 5% to 10% of current body weight. Body mass index and waist circumference are 2 key measures of body fat. A wide variety of tools are available to assess obesity-related risk factors and guide management.

Entities:  

Mesh:

Year:  2014        PMID: 25198218

Source DB:  PubMed          Journal:  J Fam Pract        ISSN: 0094-3509            Impact factor:   0.493


  11 in total

1.  CYP1B1 deficiency ameliorates obesity and glucose intolerance induced by high fat diet in adult C57BL/6J mice.

Authors:  Xiaocong Liu; Tingting Huang; Lu Li; Yumeng Tang; Yatao Tian; Suqing Wang; Cuifang Fan
Journal:  Am J Transl Res       Date:  2015-04-15       Impact factor: 4.060

2.  Patient comorbidities increase postoperative resource utilization after laparoscopic and open cholecystectomy.

Authors:  Jacqueline Boehme; Sophia McKinley; L Michael Brunt; Tina D Hunter; Daniel B Jones; Daniel J Scott; Steven D Schwaitzberg
Journal:  Surg Endosc       Date:  2015-10-01       Impact factor: 4.584

3.  Development of murine bariatric surgery models: lessons learned.

Authors:  Heather A Frohman; Piotr G Rychahou; Jing Li; Tong Gan; B Mark Evers
Journal:  J Surg Res       Date:  2018-05-10       Impact factor: 2.192

Review 4.  Anti-ghrelin antibodies in appetite suppression: recent advances in obesity pharmacotherapy.

Authors:  Velimir Altabas; Vanja Zjačić-Rotkvić
Journal:  Immunotargets Ther       Date:  2015-07-09

5.  Coadministration of lorcaserin and phentermine for weight management: A 12-week, randomized, pilot safety study.

Authors:  Steven R Smith; W Timothy Garvey; Frank L Greenway; Sharon Zhou; Randi Fain; Robert Pilson; Ken Fujioka; Louis J Aronne
Journal:  Obesity (Silver Spring)       Date:  2017-05       Impact factor: 5.002

6.  Targeting metabolic disorders by natural products.

Authors:  Bagher Larijani; Mohammad Abdollahi; Ozra Tabatabaei-Malazy
Journal:  J Diabetes Metab Disord       Date:  2015-07-08

7.  A randomized controlled trial to evaluate the effects of high Protein Complete (lActo) VEgetaRian (PACER) diet in non-diabetic obese Asian Indians in North India.

Authors:  Swati Bhardwaj; Anoop Misra; Seema Gulati; Shajith Anoop; Vineet Kumar Kamal; Ravindra Mohan Pandey
Journal:  Heliyon       Date:  2018-01-11

Review 8.  Weight Loss in Advanced Chronic Kidney Disease: Should We Consider Individualised, Qualitative, ad Libitum Diets? A Narrative Review and Case Study.

Authors:  Irene Capizzi; Luigi Teta; Federica Neve Vigotti; Giuliana Tognarelli; Valentina Consiglio; Stefania Scognamiglio; Giorgina Barbara Piccoli
Journal:  Nutrients       Date:  2017-10-11       Impact factor: 5.717

9. 

Authors:  Elenara Simoni Kovaleski; Helena Schroeder; Mauricio Krause; Caroline Dani; Patrícia Martins Bock
Journal:  J Vasc Bras       Date:  2016 Jul-Sep

10.  Long-term sucrose solution consumption causes metabolic alterations and affects hepatic oxidative stress in Wistar rats.

Authors:  Ellen Mayara Souza Cruz; Juliana Maria Bitencourt de Morais; Carlos Vinícius Dalto da Rosa; Mellina da Silva Simões; Jurandir Fernando Comar; Luiz Gustavo de Almeida Chuffa; Fábio Rodrigues Ferreira Seiva
Journal:  Biol Open       Date:  2020-02-28       Impact factor: 2.422

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.